Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

Fetal Tissue, Stem Cells & Bioethics

134 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
134 results
featured-image
Fetal Tissue, Stem Cells & Bioethics

Maryland Joins the Trend for Ethical Stem Cell Research

This paper continues the investigation of stem cell research funding in the United States by examining the funding patterns at the Maryland Stem Cell Research Commission. This investigation reveals that the Maryland Commission is keeping with the trend of investing more money in ethical stem cell research as opposed to embryonic as it is this route which is providing demonstrable results.

Eugene C. Tarne
October 1, 2013
ClosePlease login
featured-image
Fetal Tissue, Stem Cells & Bioethics

Adult Stem Cells Imitate Human Brain, Are Hope for Neurological Disorders

A study published last week has shown that ethical adult stem cells can be used to create three-dimensional living tissues that imitate the developing human brain.  In their findings, published in the science journal Nature, researchers asserted that, by using human stem cells derived from skin cells, they were able to assemble brain-like pieces of living tissue.  These stem cells could prove to be an invaluable resource for the treatment and study of various neuro-developmental disorders.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Stem Cell Alternative Campaign Progressing in the European Union

A European grassroots initiative with the bold objective of protecting human life even in its most vulnerable embryonic state has gained considerable support across the continent- collecting over 850,000 signatures from a wide array of nations. The “One of Us” initiative is a valiant effort that has been taken up by groups and individuals across the Europe with the aim of advancing the protection of the human embryo.

featured-image
Fetal Tissue, Stem Cells & Bioethics

The Science and Politics of Cloning: What the News Was All About

In this paper, Dr. Maureen Condic of the University of Utah explains the derivation of human stem cells from cloned human embryos. Dr. Condic discuss the science and politics behind cloning and why this method is unlikely to ever be the preferred tool of regenerative medicine.

featured-image
Fetal Tissue, Stem Cells & Bioethics

New California Grants Once Again Bolster Ethical Stem Cell Alternatives

The most recent round of grants by the California Institute for Regenerative Medicine (CIRM) demonstrates – again – where the future of stem cell research lies.

featured-image
Fetal Tissue, Stem Cells & Bioethics

UK Government Panel Approves Genetically Engineered “Three-Parent” Embryos

Great Britain’s Human Fertilisation and Embryology Authority (HFEA), which oversees fertility treatments and embryo research in that nation, recently approved fertility procedures that would amount to the genetic engineering of children through cloning (nuclear transfer) technology and germ-line modification, resulting in a “three-parent embryo” that would have genetic material from two mothers and one father.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Living up to Potential: Prospects for a Midwest Center for Stem Cell Therapy

The following is the written testimony of Dr. Prentice before a Joint Meeting of the Committee on Public Health and Welfare, Kansas Senate and the Committee on Health and Human Services, Kansas House.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Major Step Forward for Ethical Stem Cell Research

A major New England biotech company recently announced that it would begin the process that it hopes will result in the first clinical trial using induced pluripotent stem cells (iPSCs).

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image